EMERYVILLE, Calif.,
Sept. 8, 2021 /PRNewswire/
-- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic
biotechnology company in Clean Health and Beauty markets through
its consumer brands and a top supplier of sustainable and natural
ingredients, today announced that management will present at
two upcoming investor conferences and provide a business
update.
- H.C. Wainwright 23rd Annual Global Investment
Conference, September 13 from
7:00 AM ET for on-demand viewing
- Cowen's 2nd Annual Health, Wellness & Beauty Summit,
September 13 at 2:10 PM ET
A webcast of the presentations and replays will be made
available on the Investor Relations section of the company's
website at http://investors.amyris.com.
About Amyris
Amyris (Nasdaq: AMRS) is a science and technology leader in the
research, development and production of sustainable ingredients for
the Clean Health & Beauty and Flavors & Fragrances markets.
Amyris uses an impressive array of exclusive technologies,
including state-of-the-art machine learning, robotics and
artificial intelligence. Our ingredients are included in over
20,000 products from the world's top brands, reaching more than 300
million consumers. Amyris is proud to own and operate a family of
consumer brands - all built around its No Compromise® promise of
clean ingredients: Biossance® clean beauty
skincare, Pipette® clean baby skincare,
Purecane™, a zero-calorie sweetener naturally derived from
sugarcane, Terasana® clean skincare treatment,
Costa Brazil luxury skincare, OLIKA hygiene and wellness, Rose
Inc.™ clean color cosmetics and JVN™ clean haircare. For more
information, please visit http://www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette,
Purecane, Terasana, Rose Inc. and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original
content:https://www.prnewswire.com/news-releases/amyris-to-present-at-two-september-investor-conferences-301371160.html
SOURCE Amyris, Inc.